about
Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatinModulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity.Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells.[Reirradiation of normal tissues: preclinical radiobiological data].Lung cancer stem cell: new insights on experimental models and preclinical data.Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cellsEnhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesis.Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines.Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration.Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expressionTherapeutic management of intestinal fibrosis induced by radiation therapy: from molecular profiling to new intervention strategies et vice et versaComparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars.Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be aheadMaintenance of radiation-induced intestinal fibrosis: cellular and molecular featuresRho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity.Molecular aspects of intestinal radiation-induced fibrosis.Cardiac Radionuclide Imaging in Rodents: A Review of Methods, Results, and Factors at Play.Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity.TAT-RasGAP317-326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death.How could breast cancer molecular features contribute to locoregional treatment decision making?The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer.High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber.The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.PrP(c) deficiency and dasatinib protect mouse intestines against radiation injury by inhibiting of c-Src.Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines.Promoter sequences involved in transforming growth factor beta1 gene induction in HaCaT keratinocytes after gamma irradiation.Fc-receptor-mediated intracellular delivery of Cu/Zn-superoxide dismutase (SOD1) protects against redox-induced apoptosis through a nitric oxide dependent mechanism.The myofibroblast markers α-SM actin and β-actin are differentially expressed in 2 and 3-D culture models of fibrotic and normal skin.Expression of matrix metalloproteinases and tissue inhibitor metalloproteinases increases in X-irradiated rat ileum despite the disappearance of CD8a T cells.Tissue toxicity induced by ionizing radiation to the normal intestine: understanding the pathophysiological mechanisms to improve the medical management.Radiosensitivity of human papillomavirus-related tumors: in regard to Gupta et al. (Int J Radiat Oncol Biol Phys 2009;74:928-933).What have we learned from human papillomavirus-positive tumors? Trying to connect data about biomarkers among human papillomavirus-related squamous cell carcinomas.Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses.A need for biology-driven personalized radiotherapy in breast cancer.High dose-per-pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use.Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s.Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridization.High dose-per-pulse electron beam dosimetry: Usability and dose-rate independence of EBT3 Gafchromic films.
P50
Q24646870-4F1F0B04-3077-4896-B1FE-0AE6C44E762BQ30484563-7208E7FD-EB0D-42BE-AED1-9937FB96FAAEQ33422883-1AE41C1F-E565-4E21-9E82-2D3792E873BEQ33667915-9C50755B-003E-47D1-9F00-F30C44C7B657Q33786637-E5EC9EBB-2BEF-45F3-BA07-F0012A2B4818Q34055939-306A9103-5229-4609-A334-4EA1D693CB4EQ34602939-4BA2AED4-3139-492B-8178-CDED46C415AFQ35067562-12D6458D-E7C2-414E-9EC1-023899041FD0Q35551808-12C7AFA5-8C90-4493-8A7D-5B777CE295EFQ35597228-102FBE99-276C-405E-9197-ED8459F5205FQ36012545-932DA19A-C736-4CE5-B0B4-C6254DFD8AE6Q36030447-CE75404E-ABBF-4CCD-8F5B-BCD739A2AB77Q36089944-D008841F-15C9-4759-BC7D-48C46FEA2DD9Q36849440-D245795C-583B-499C-99A6-9C49C2CE6CC9Q36912563-5DD77D2D-95AB-4A16-97DB-54289E68C68FQ37438176-E99F044D-D073-4F45-A878-1E20B934D36CQ37729498-1F1622A9-4C5D-45D1-9388-842035E31841Q37736757-068D42F6-F3F3-4FEB-9A18-2B26DE515EEAQ38711276-B1987F4B-2114-407D-826B-C8231E6E49E4Q38767578-A3D0FB67-9BF6-4348-9332-4B3AE2370231Q38861440-BF43BBCB-E374-4BDE-AB43-2021065FDD20Q38891937-48BCA3F1-91B0-4E2D-9662-709D383959CAQ39017054-B554547F-C18C-43D0-8215-A582B1C95FE7Q39148585-B8DC54FD-88E8-44BF-8493-F0712DF52BE6Q39608738-9528F32D-00F2-4A8E-B315-306E7A626458Q39834813-A7C11A03-BD27-41AF-950D-14F4B90ED8C9Q40226479-E2F34E84-289C-446E-9FC3-C561B4E12F12Q40751727-E75A1D7B-B50B-4870-9313-E97C2B9911B8Q40789813-21C77A58-F962-47F6-A5E3-3211A31B8498Q41852259-F8E9E437-4822-4769-ABEF-242BC016FF2AQ42104313-764F6B31-EBAF-4A07-A781-74E069B26F6FQ42911333-5E47558C-F3C4-4D75-B08A-65B3B8357475Q43504091-32BF932E-2B20-4F27-9DFD-C0FD0135484FQ43536244-F356954C-C6F7-4C35-8ABC-C170BB3A6DB0Q46454456-EF045BE1-359E-4E93-AF95-15350265812DQ48283335-25277643-4105-47EE-A6B1-6463C19BE04DQ50070053-EEA57991-A5B3-4EA2-B13D-6BE810F2C997Q50436746-402D7C0F-6F37-4527-84BD-16E95DDF23BEQ51021035-2ACFB61C-B084-45A0-B120-D40B909CE9BAQ51066581-A755596E-0EAF-43FB-81A3-28E471CFB1B7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marie-Catherine Vozenin
@ast
Marie-Catherine Vozenin
@en
Marie-Catherine Vozenin
@es
Marie-Catherine Vozenin
@nl
Marie-Catherine Vozenin
@sl
type
label
Marie-Catherine Vozenin
@ast
Marie-Catherine Vozenin
@en
Marie-Catherine Vozenin
@es
Marie-Catherine Vozenin
@nl
Marie-Catherine Vozenin
@sl
prefLabel
Marie-Catherine Vozenin
@ast
Marie-Catherine Vozenin
@en
Marie-Catherine Vozenin
@es
Marie-Catherine Vozenin
@nl
Marie-Catherine Vozenin
@sl
P106
P21
P31
P496
0000-0002-2109-8073